Medicamen Biotech share news, announcements and annual reports
NSE: MEDICAMEQBSE: 531146Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹254.25.
29 Oct: open ₹258.90, high ₹266.95, low ₹250.00
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹375 Cr1,991st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.36
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.37%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.17
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 16,376
Medicamen Biotech has 196 announcements on record, routine notices left out; 1 in the 30 days to 30 Oct 2026, the latest on 23 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Medicamen Biotech quarterly results
The board met on 14 Aug 2026 to consider financial results
Notice filed 7 Aug 2026
To consider and approve the financial results for the period ended Jun 30, 2026
Medicamen Biotech annual reports, presentations and earnings calls
The company's own documents, latest first.Medicamen Biotech financials, year by year
Annual reports5
- Annual report, year to Mar 20263 Sep 2026
- Annual report, year to Mar 20253 Sep 2025
- Annual report, year to Mar 20242 Sep 2024
- Annual report, year to Mar 20232 Sep 2023, a zip file
- Annual report, year to Mar 20223 Sep 2022, a zip file
Investor presentations1
- Investor Presentation4 Dec 2021
Medicamen Biotech share news and announcements
Newest first. Page 1 of 4.
Oct 2026
Sep 2026
30 Sep · Trading Plan under PIT
Aug 2026
14 Aug · Corporate action
14 Aug · Results
7 Aug · Board meeting
Jun 2026
May 2026
28 May · Business
27 May · Results
Apr 2026
6 Apr · Disclosure of material issue
Feb 2026
21 Feb
13 Feb · Management
13 Feb · Results
13 Feb · Board meeting
4 Feb · Board meeting
Jan 2026
Nov 2025
14 Nov · Results
Sep 2025
Aug 2025
12 Aug · Management
12 Aug · Results
12 Aug · Board meeting
7 Aug · Board meeting
Jun 2025
May 2025
30 May · Results
Apr 2025
25 Apr · Board meeting
25 Apr · Board meeting
8 Apr
3 Apr
Mar 2025
28 Mar
22 Mar · Trading Plan under PIT
7 Mar
5 Mar · Updates
Feb 2025
27 Feb
26 Feb
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 17 Aug 2026Resultsdown 8.55%−8.4 pts vs Nifty 500market median −0.7% · five sessions +1.7% (+2.0 pts vs Nifty 500) · volume 4.3× usual · delivery +6.0 pts against usual · The announcement
- 29 May 2026Resultsdown 4.59%−3.2 pts vs Nifty 500market median −0.7% · five sessions −10.2% (−8.1 pts vs Nifty 500) · volume 3.7× usual · delivery +2.2 pts against usual · The announcement
- 16 Feb 2026Resultsdown 4.03%−4.7 pts vs Nifty 500market median −0.7% · five sessions −10.5% (−10.9 pts vs Nifty 500) · volume 1.2× usual · delivery +13.7 pts against usual · The announcement
- 16 Feb 2026Board or managers changeddown 4.03%−4.7 pts vs Nifty 500market median 0.0% · five sessions −10.5% (−10.9 pts vs Nifty 500) · volume 1.2× usual · delivery +13.7 pts against usual · The announcement
- 17 Nov 2025Resultsdown 3.46%−4.0 pts vs Nifty 500market median −0.7% · five sessions −2.4% (−2.2 pts vs Nifty 500) · volume 1.8× usual · delivery −9.5 pts against usual · The announcement
- 13 Aug 2025Resultsdown 3.72%−4.3 pts vs Nifty 500market median −0.7% · five sessions −0.3% (−2.8 pts vs Nifty 500) · volume 1.3× usual · delivery −2.6 pts against usual · The announcement
- 13 Aug 2025Board or managers changeddown 3.72%−4.3 pts vs Nifty 500market median 0.0% · five sessions −0.3% (−2.8 pts vs Nifty 500) · volume 1.3× usual · delivery −2.6 pts against usual · The announcement
- 2 Jun 2025Resultsdown 2.32%−2.5 pts vs Nifty 500market median −0.7% · five sessions −1.0% (−2.6 pts vs Nifty 500) · volume 2.2× usual · delivery +2.4 pts against usual · The announcement
- 12 Feb 2025Resultsdown 2.00%−1.8 pts vs Nifty 500market median −0.7% · five sessions −1.5% (+0.1 pts vs Nifty 500) · volume 2.2× usual · delivery +12.8 pts against usual · The announcement
- 13 Aug 2024Resultsdown 4.27%−3.3 pts vs Nifty 500market median −0.7% · five sessions +1.2% (−0.4 pts vs Nifty 500) · volume 1.7× usual · delivery +7.3 pts against usual · The announcement
8 earlier announcements
- 26 Jul 2024Board or managers changeddown 0.64%−2.3 pts vs Nifty 500market median 0.0% · five sessions −4.5% (−7.0 pts vs Nifty 500) · volume 0.4× usual · delivery 0.0 pts against usual · The announcement
- 30 May 2024Dividenddown 4.78%−3.8 pts vs Nifty 500market median 0.0% · five sessions −8.3% (−7.3 pts vs Nifty 500) · volume 1.1× usual · delivery +0.6 pts against usual · The announcement
- 12 Nov 2023Resultsdown 0.03%−0.6 pts vs Nifty 500market median −0.7% · five sessions −0.7% (−2.6 pts vs Nifty 500) · volume 0.2× usual · delivery +2.2 pts against usual · The announcement
- 30 May 2023Dividenddown 2.08%−2.3 pts vs Nifty 500market median 0.0% · five sessions −2.9% (−3.5 pts vs Nifty 500) · volume 1.5× usual · delivery −10.1 pts against usual · The announcement
- 14 Nov 2022Resultsdown 4.78%−4.8 pts vs Nifty 500market median −0.7% · five sessions −3.0% (−2.3 pts vs Nifty 500) · volume 0.9× usual · delivery −6.5 pts against usual · The announcement
- 11 Aug 2022Resultsdown 0.82%−1.5 pts vs Nifty 500market median −0.7% · five sessions −2.4% (−5.2 pts vs Nifty 500) · volume 0.9× usual · delivery −2.7 pts against usual · The announcement
- 26 May 2022Resultsup 2.21%+1.2 pts vs Nifty 500market median −0.7% · five sessions +9.5% (+5.8 pts vs Nifty 500) · volume 1.2× usual · delivery +4.2 pts against usual · The announcement
- 9 Feb 2022Resultsdown 7.19%−8.3 pts vs Nifty 500market median −0.7% · five sessions −17.2% (−16.8 pts vs Nifty 500) · volume 3.0× usual · delivery −8.0 pts against usual · The announcement
Medicamen Biotech results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Tax | Quarter to Jun 2024 | Consolidated | 0.76 | 0.69 | −8.9% | 26 Aug 2024 | 15 Nov 2024 |
| Net profit | Quarter to Jun 2024 | Consolidated | 0.80 | 0.87 | +8.4% | 26 Aug 2024 | 15 Nov 2024 |
| Deferred tax | Quarter to Jun 2024 | Consolidated | −0.08 | −0.15 | −86.4% | 26 Aug 2024 | 15 Nov 2024 |
| Net profit from continuing businesses | Quarter to Jun 2024 | Consolidated | 0.80 | 0.87 | +8.4% | 26 Aug 2024 | 15 Nov 2024 |
| Total comprehensive income | Quarter to Jun 2024 | Consolidated | 0.80 | 0.87 | +8.4% | 26 Aug 2024 | 15 Nov 2024 |
| Net profit belonging to the company's shareholders | Quarter to Jun 2024 | Consolidated | 1.35 | 0.87 | −35.9% | 26 Aug 2024 | 15 Nov 2024 |